PTEN and hepatocellular carcinoma: Because PTEN antagonizes the AKT signaling pathway by dephosphorylating phosphoinositide [31, 32], we assessed levels of phosphorylation of AKT (p-AKT) in HCC cells treated by UBE2S-knockdown, FOXM1-overexpression and a combination of both.